Literature DB >> 18068301

Mutation analysis of the parkin and PINK1 genes in American Caucasian early-onset Parkinson disease families.

Hao Deng1, Weidong Le, Joohi Shahed, Wenjie Xie, Joseph Jankovic.   

Abstract

Mutations in the parkin gene and the PTEN-induced putative kinase 1 gene (PINK1) have been identified as the most common causes of autosomal recessive early-onset Parkinson disease (EOPD). To investigate the presence of the parkin and PINK1 gene mutation(s) and to explore genotype-phenotype correlations in American Caucasian families with EOPD from North American, we screened these two genes in probands of six families by direct sequencing, semi-quantitative PCR and RT-PCR. No PINK1 gene mutation was found in any of the probands, but compound heterozygous mutations (EX 3 del and EX 3_4 del) in the parkin gene were identified in one family. Extended analysis of the parkin-positive family showed the phenotype of patients was that of classic autosomal recessive EOPD, characterized by early age at onset, slow progression, beneficial response to levodopa, and levodopa-related motor complications. Three heterozygous mutation carriers (EX 3 del or EX 3_4 del) were free of any neurological symptoms. None of 62 healthy controls harbored EX 3 del or EX 3_4 del mutation. Our data suggest that compound heterozygous mutations (EX 3 and EX 3_4 del) in the parkin gene were the cause of EOPD in one of six Caucasian families; heterozygous EX 3 del and heterozygous EX 3_4 del forms were insufficient to cause this disorder, consistent with a loss-of-function mechanism of the parkin mutations. The results may provide new insights into the cause and diagnosis of PD and have implications for genetic counseling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18068301     DOI: 10.1016/j.neulet.2007.10.018

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

1.  Quercetin glycosides induced neuroprotection by changes in the gene expression in a cellular model of Parkinson's disease.

Authors:  Kasthuri Bai Magalingam; Ammu Radhakrishnan; Premdass Ramdas; Nagaraja Haleagrahara
Journal:  J Mol Neurosci       Date:  2014-08-17       Impact factor: 3.444

2.  Protecting Effects of N-acetyl Cysteine Supplementation Against Lead and Cadmium-Induced Brain Toxicity in Rat Models.

Authors:  MohammadMahdi Jaafarzadeh; Roham Mahjoob Khaligh; Zhaleh Mohsenifar; Aida Shabani; MohammadMahdi Rezvani Gilkalaei; Sara Rajabi Keleshteri; Asghar Beigi Harchegani
Journal:  Biol Trace Elem Res       Date:  2021-11-24       Impact factor: 4.081

3.  Incorporating genetics and genomics in risk assessment for inhaled manganese: from data to policy.

Authors:  Christine P Curran; Robert M Park; Shuk-mei Ho; Erin N Haynes
Journal:  Neurotoxicology       Date:  2009-07-29       Impact factor: 4.294

4.  Psychological Stress Phenocopies Brain Mitochondrial Dysfunction and Motor Deficits as Observed in a Parkinsonian Rat Model.

Authors:  Mariana Grigoruţă; Alejandro Martínez-Martínez; Raul Y Dagda; Ruben K Dagda
Journal:  Mol Neurobiol       Date:  2019-12-14       Impact factor: 5.590

Review 5.  Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update.

Authors:  Karen Nuytemans; Jessie Theuns; Marc Cruts; Christine Van Broeckhoven
Journal:  Hum Mutat       Date:  2010-07       Impact factor: 4.878

Review 6.  Genetics of Parkinson's disease - a clinical perspective.

Authors:  Sang-Myung Cheon; Lilian Chan; Daniel Kam Yin Chan; Jae Woo Kim
Journal:  J Mov Disord       Date:  2012-10-30

7.  T313M polymorphism of the PINK1 gene in Parkinson's disease.

Authors:  Qin Luo; Xinling Yang; Yani Yao; Hongjuan Li; Yuling Wang
Journal:  Exp Ther Med       Date:  2014-05-08       Impact factor: 2.447

Review 8.  MicroRNAs and Target Genes As Biomarkers for the Diagnosis of Early Onset of Parkinson Disease.

Authors:  Ahmad R Arshad; Siti A Sulaiman; Amalia A Saperi; Rahman Jamal; Norlinah Mohamed Ibrahim; Nor Azian Abdul Murad
Journal:  Front Mol Neurosci       Date:  2017-10-31       Impact factor: 5.639

9.  Whole exome sequencing identified a new compound heterozygous PRKN mutation in a Chinese family with early-onset Parkinson's disease.

Authors:  Tianbai Li; Daqing Kou; Yanhua Cui; Weidong Le
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.